President Trump escalates trade war by targeting the copper market with threats of imposing 50% tariffs on imports, impacting semiconductor and electric vehicle markets.
Copper futures surged over 10% following the announcement, prompting investors to consider taking profits amidst the uncertainty. Companies like Freeport-McMoran and Teck may be at risk of a downtrend.
Pharmaceutical stocks showed resilience despite threats of higher tariffs by President Trump, with major companies like Merck, Johnson & Johnson, Novartis, and Novo Nordisk trading higher. Bristol-Myers, Pfizer, and AstraZeneca are recommended as attractive stocks due to their cheap valuations.
Market sentiment remains relatively calm towards daily tariff threats, with expectations that any significant tariff implementation may not occur for 12-18 months, potentially influenced by future political changes. A panic-induced sell-off is deemed unlikely until detailed tariff rate agreements are signed.